- Specialization in MASH/MASLD, obesity, type 1 diabetes, CHF, PAH, metabolic syndrome, & related conditions
- Expertise in both acute & chronic disease trials
- Robust data management & analytical support
- Extensive site and KOL relationships
For your next cardiovascular or metabolic trial, leverage tailored solutions from a global leader in clinical research.
Learn about our cardiovascular & metabolic clinical development servicesWe’re committed to working with sponsors who are driving change for the global populations impacted by cardiovascular and metabolic diseases. Our project teams are dedicated exclusively to supporting cardiovascular and metabolic clinical development with a specialized focus on cardiovascular-kidney-metabolic syndromes and co-morbidities.
We bring together a multidisciplinary team of experts in various fields, including gastroenterology, cardiology, endocrinology, and nephrology, to provide integrated medical and scientific advice on study designs, appropriate endpoints, and patient-reported outcomes for trial success. Together with our extensive site and KOL relationships, we’re ready to take on the challenges of your cardiovascular or metabolic trial and drive forward patient-centric trials.
Meet our team and see how our approach can make a difference in your cardiovascular or metabolic trial.
As a cardiovascular and metabolic CRO, we’re committed to delivering the best solutions and up-to-date resources for your trial. We work cross-departmentally to provide an integrated trial experience that supports better patient safety, enrollment, engagement, and retention.
Enrolled Patients
Sites
Countries
We have highly specialized teams that are dedicated to the indications they support. We specialize in small molecule, biologics, and advanced therapies for cardiovascular-kidney-metabolic syndrome, diabetes, obesity, MASH, lipid disorders, and liver diseases. We provide modality-specific support to ensure your trial benefits from our comprehensive expertise.
Your patients are important to us, and we take extensive measures to ensure your trial works for real patients. We optimize study design, develop patient-friendly study materials, and embed the patient voice in everything we do, aiming to reduce the burden of participation for patients and sites. We also provide comprehensive therapeutically aligned site education on medical bias and disease processes. With our highly qualified contacts, sites can expect clear and frequent communication channels.
Complex trials don’t have to be complicated. Partnering with an experienced cardiovascular and metabolic CRO can simplify the process. We support innovative trial designs and have relationships with key opinion leaders (KOLs) and sites necessary to develop and enroll trials. We offer the resources to support logistics and data management for complex studies. No matter the complexities your study faces, we have the solutions.
Your experience is important to us.
President, Cardiovascular & Metabolic
Vice President Project Management, Cardiovascular
Senior Director Therapeutic Strategy Lead Metabolic
Executive Director, Project Management, MASH, Cardiovascular & Metabolic
Executive Director, Medical Affairs & Therapeutic Area Lead, Digestive Diseases
Executive Director, Scientific Solutions, Cardiovascular, Endocrine & Metabolic